XMW:CA:TSX-iShares MSCI Min Vol Global Index ETF (CAD)

ETF | Global Equity |

Last Closing

CAD 54.27

Change

-0.29 (-0.53)%

Market Cap

CAD 0.18B

Volume

1.10K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Global Equity

Symbol Name Price(Change) Market Cap
VEQT:CA Vanguard All-Equity ETF Portfo..

-0.04 (-0.09%)

CAD 5.22B
XAW:CA iShares Core MSCI All Country ..

-0.12 (-0.28%)

CAD 2.66B
VXC:CA Vanguard FTSE Global All Cap e..

-0.07 (-0.11%)

CAD 2.09B
XWD:CA iShares MSCI World Index ETF

-0.18 (-0.20%)

CAD 1.04B
TGED:CA TD Active Global Enhanced Divi..

+0.04 (+0.16%)

CAD 0.80B
ZGQ:CA BMO MSCI All Country World Hig..

+0.19 (+0.28%)

CAD 0.74B
HAZ:CA Global X Active Global Dividen..

-0.06 (-0.16%)

CAD 0.46B
XDG:CA iShares Core MSCI Global Quali..

-0.01 (-0.04%)

CAD 0.40B
CYH:CA iShares Global Monthly Dividen..

-0.23 (-1.03%)

CAD 0.15B
ETHI:CA Global X Global Sustainability..

+0.05 (+0.09%)

CAD 0.11B

ETFs Containing XMW:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Global Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.84% 42% F 66% D+
Dividend Return 0.67% 35% F 20% F
Total Return 16.51% 50% F 63% D
Trailing 12 Months  
Capital Gain 18.49% 8% B- 48% F
Dividend Return 2.05% 77% C+ 37% F
Total Return 20.55% 25% F 48% F
Trailing 5 Years  
Capital Gain 20.73% 17% F 50% F
Dividend Return 6.84% 50% F 23% F
Total Return 27.58% 13% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 3.38% N/A N/A 50% F
Dividend Return 4.81% N/A N/A 50% F
Total Return 1.42% N/A N/A 46% F
Risk Return Profile  
Volatility (Standard Deviation) 6.14% N/A N/A 90% A-
Risk Adjusted Return 78.29% N/A N/A 88% B+
Market Capitalization 0.18B 58% F 44% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.